Insilico Targets MTAP Deleted Cancers with AI-Designed Candidate
Michelle Chen, PhD, Insilico Medicine Chief business officer Insilico Medicine is heading to the clinic with its seventh pipeline candidate discovered and designed using generative artificial intelligence (AI), a treatment for methylthioadenosine …